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o track the behavior of human immunodeﬁciency virus
(HIV)-1 in the cytoplasm of infected cells, we have
tagged virions by incorporation of HIV Vpr fused to
the GFP. Observation of the GFP-labeled particles in living
cells revealed that they moved in curvilinear paths in the
cytoplasm and accumulated in the perinuclear region, often
near the microtubule-organizing center. Further studies
show that HIV uses cytoplasmic dynein and the microtubule
network to migrate toward the nucleus. By combining GFP
fused to the NH
 
2
 
 terminus of HIV-1 Vpr tagging with other
T
 
labeling techniques, it was possible to determine the state of
progression of individual particles through the viral life cycle.
Correlation of immunoﬂuorescent and electron micrographs
allowed high resolution imaging of microtubule-associated
structures that are proposed to be reverse transcription
complexes. Based on these observations, we propose that
HIV uses dynein and the microtubule network to facilitate
the delivery of the viral genome to the nucleus of the cell
during early postentry steps of the HIV life cycle.
 
Introduction
 
After CD4 and coreceptor-dependent fusion of human immu-
nodeficiency virus (HIV)* with the cellular membrane, several
events must occur before the HIV genomic DNA can be
inserted into the genome of the cell. After entry into the cyto-
plasm, the infectious particle must lose some of its virion
proteins, acquire some cellular factors, convert its RNA genome
into the DNA preintegration form, and ultimately integrate
into the genome of the infected cell (for review see Cullen,
2001). All of these events have been biochemically defined,
but a clear understanding of these processes, how and when
they occur, has been hampered by an inability to directly
observe the events in infected cells.
HIV infects nondividing cells by delivering its genome
into the nucleus through nuclear pores. To reach the pores
in the nuclear envelope, the genome must travel from the
plasma membrane through the cytoplasm. The integration
competent particle, called the preintegration complex, has
been estimated to be at least 50 nm in diameter (Miller et
al., 1997). Because of the high viscosity of the cytoplasm,
movement of these particles by diffusion is likely to be very
limited (for review see Luby-Phelps, 2000). Some viruses over-
come this obstacle by hijacking cytoplasmic motors to utilize
the cellular cytoskeleton as a roadway. For instance, herpes
simplex virus (HSV)-1 (Sodeik et al., 1997) and adenovirus
(Ad; Suomalainen et al., 1999) are thought to use dynein
motors to travel along the microtubule network for intra-
cellular transport. To characterize the intracellular trafficking
of HIV, we have developed several fluorescence-based methods
that allow the detection and characterization of individual
intracellular complexes of viral origin. Importantly, several of
these labeling methods allow the visualization of individual
virions in living cells. Observation of intracellular HIV in liv-
ing cells revealed that HIV moves in the cytoplasm in curvi-
linear paths. Further analysis revealed that intracellular HIV
is associated with microtubules and uses cytoplasmic dynein
to move toward the nucleus of the cell. These studies sug-
gest that the intracellular trafficking of the HIV genome is
a highly ordered process using cellular motor pathways.
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Results
 
GFP–Vpr is incorporated into intact infectious 
HIV-1 virions
 
To track viral-derived complexes in the cytoplasm of infected
cells, we wanted to stably incorporate the GFP into the HIV
virion core by fusion to the HIV accessory protein Vpr. Vpr is
incorporated into the virion through interaction with the gag
p6 region during viral assembly (Paxton et al., 1993). On av-
erage, 100–200 Vpr molecules are incorporated into a single
virion produced during normal HIV replication, and much
greater amounts can be incorporated when Vpr is overex-
pressed in trans (Muller et al., 2000; Singh et al., 2001). Im-
portantly, Vpr remains associated with the DNA form of the
viral genome in the cytoplasm (Fassati and Goff, 2001).
We generated labeled replication competent virus stocks by
cotransfection of HIV proviral DNA with a plasmid that ex-
presses GFP fused to the NH
 
2
 
 terminus of HIV-1
 
 
 
Vpr (GFP–
Vpr). After target cells were exposed to the virus-containing
supernatants, point sources of GFP fluorescence were found
associated with the infected cells, presumably marking the
presence of the GFP–Vpr-tagged intracellular particles (Fig.
1). Adherent human cells expressing CD4 were used in these
studies because their flat morphology provides an extended
cytoplasm, allowing greater resolution of cellular compart-
ments. Early in infection, the GFP signal appeared as punctate
signals spread throughout the cell (Fig. 1 A), and when the
target cells were washed of free virus and allowed to incubate
further, a significant proportion of the signal accumulated in
the perinuclear region, often at the microtubule-organizing
center (MTOC), in as little as 2 h (Fig. 1 B).
Indirect immunofluorescent staining of the GFP–Vpr-
tagged HIV bound to glass coverslips confirmed that virtu-
ally all of the observed GFP fluorescence was associated with
the viral matrix (p17
 
MA
 
) (Fig. 2 A) and capsid (p24
 
CA
 
) (Fig.
2 B) proteins. Typically 50–80% of the particles identified
by HIV gag protein were strongly labeled with GFP–Vpr.
70% are labeled with GFP in the experiment shown as dem-
onstrated by costaining for either p24
 
CA
 
 or p17
 
MA
 
. The colo-
calization of HIV gag proteins with GFP fluorescence sug-
gests that we can detect more than half of the virions by
GFP fluorescence in these experiments.
To determine whether the GFP-tagged HIV particles con-
tained cell-derived membranes, we exposed the transfected
virus-producing cells to the lipophilic membrane dye DiD
(DiIC
 
18
 
; Molecular Probes) before collecting the superna-
tants. As expected, essentially all of the GFP fluorescence
colocalized with the membrane dye (Fig. 2 C). As seen with
gag-specific immunostaining, several GFP-low or -negative,
dye-positive spots were observed. This suggested the pres-
ence either of viral particles that did not incorporate enough
of the GFP–Vpr fusion to be easily detected or possibly of
nonviral, lipid-containing cellular debris. We next estab-
lished that the GFP–Vpr fusion migrated with intact virions
on a sedimentation gradient. For this experiment, HIV lack-
ing the native envelope, and therefore unable to replicate,
was used to avoid biosafety concerns related to concentrat-
ing HIV. When GFP–Vpr-labeled viral supernatants were
loaded onto the gradient, the GFP–Vpr fusion copurified
with HIV p24
 
CA
 
, indicating specific incorporation into viral
particles (Fig. 2 D). The GFP–Vpr fusion was absent from
the bottom fraction where membrane debris and intracellu-
lar vesicles migrate. Importantly, the fusion protein re-
mained largely intact, insuring that the fluorescent tag
should remain attached to the complex containing the HIV
genome. Together, these results indicate that the GFP–Vpr
fusion protein allows the detection of individual HIV viri-
ons by fluorescent microscopy.
Figure 1. Infection with EGFP–Vpr-labeled HIV results in perinuclear accumulation of point sources of Gfp fluorescence. Supernatant of 
293T cells transfected with pLAI proviral and GFP–Vpr expression plasmids was collected, filtered through a 0.4- m membrane, and transferred 
onto coverslips seeded with CD4-expressing target cells for 30 min at 37 C. Cells were rinsed and fixed in formaldehyde (A) or incubated for 
an additional 2 h (B) and fixed, then immunostained with an antitubulin antibody (red). GFP fluorescence is shown in green. Bars, 10  m. 
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HIV uses the cellular cytoskeleton to move inside of cells
 
HIV particle behavior in living cells was analyzed next. Tar-
get cells expressing CD4 and coreceptor were infected with
GFP–Vpr-labeled HIV for 30 min, and the unbound virus
was washed away (Fig. 3). In this experiment, the M-trophic
HIV strain YU-2 and target cells expressing the appropriate
CCR5 coreceptor were used. The red stain identifies mito-
chondria to visualize general cellular structure. Virus loca-
tion was monitored through a z-series of images taken every
5 min. The paths of movement of several particles during
the 95 min of observation is shown in Fig. 3 A. Individual
frames for the movement of a single particle is shown in
Fig. 3 B. The particle moves in a curvilinear path toward
the region of the nucleus (videos 1 and 2 available at http:
//www.jcb.org/cgi/content/full/jcb.200203150/DC1). To
quantify the migration of HIV within cells, we determined
the distances of individual particles from the nearest edge of
the cell and from the nuclear membrane. We reasoned that a
fractional representation of the distances (in this case the dis-
tance to the cell edge over the sum of the distances) should
give an accurate measure of relative nuclear migration, so
that particles at the periphery have positional values near 0
and particles close to the nucleus have values near 1 (Fig. 3
B). This allows the movement toward the nucleus to be
quantified even though the particles have different distances
to travel because the virus can attach anywhere on the ex-
posed surface of the cell and each cell has a distinct mor-
phology, which can change during the course of the time-
lapse experiment. To further define particle movement,
Ghost cells were used. Ghost cells contain a GFP reporter
for HIV infection and express CD4 and CXCR4 coreceptor.
Background levels of GFP expression allow the target cells to
be simultaneously observed with the GFP-labeled HIV.
Ghost cells were infected for 20 min at a low multiplicity of
infection (MOI) with GFP–Vpr-labeled HIV and then im-
aged as a z-series every 5 min after washing to determine par-
ticle motility over time. The graphical representations of the
migration of five typical particles (Fig. 3 C) shows both in-
ward and outward motion over time, but in four of the five
examples shown, significant nuclear migration occurred over
the course of the experiment, and the particles tended to re-
main near the nucleus once they arrived there. Of 19 parti-
cles from 13 different cells examined in this way, 14 (74%)
particles were in the perinuclear region at the end of the 75
min time course (unpublished data).
The nuclear-directed motion of the GFP–Vpr-labeled
particles suggested regulated movement through the cyto-
plasm. Such movement is usually a consequence of interac-
tions with cytoskeletal elements (Goosney et al., 1999; So-
deik, 2000). To determine if HIV interacts with cytoskeletal
elements, we fixed target cells at different time points after
infection and stained for either actin filaments or microtu-
bules. This analysis demonstrated a significant association of
the particles with microtubules but not with actin filaments.
In a typical experiment, 
 
 
 
90% of the intracellular particles
are within 0.5 
 
 
 
m of a microtubule immediately after infec-
Figure 2. EGFP–Vpr colocalizes with viral gag proteins and cell-derived membranes. (A and B) GFP–Vpr colocalizes with HIV gag proteins. 
Supernatant from cells transfected with GFP–Vpr and pLAI proviral constructs was exposed to clean glass coverslips in the presence of 10  g/ml 
Polybrene. Coverslips were rinsed, fixed, and immunostained with mAbs specific to p17
MA (A) and p24
CA (B). Top panels are the merged 
images so that overlapping red and green signals appear yellow. Bottom panels show the individual fluorescent images. White arrows denote 
double labeled particle; the gray arrow shows a single labeled (GFP-negative) particle. (C) GFP–Vpr colocalizes with cellular membranes. 
GFP–Vpr-labeled virus was prepared as in A with the addition of DiD (10  M; Molecular Probes) to the culture medium overnight. Free DiD 
was washed from the culture, and supernatant was collected 4 h later, bound to a coverslip as above, and fixed with formaldehyde. Bottom 
panels are separated color images. (D) GFP–Vpr is incorporated into intact HIV virions. Supernatant was collected after transfection of 293T 
cells with GFP–Vpr, pLAI  env provirus, and VSV-G constructs. Virions were pelleted by centrifugation through a 20% sucrose cushion and 
applied to an Optiprep density gradient. Fractions were collected over the entire gradient, precipitated with 10% TCA, and subjected to 
SDS-PAGE and Western blotting with antibodies specific to p24
CA (top) or GFP (bottom). A whole cell lysate of cells transfected with GFP was 
run as a control (lane C). Bars, 1  m. 
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tion, whereas only a few percent appear to coincide with fil-
amentous actin (unpublished data). The majority of parti-
cles that are not associated with microtubules are in the
peripheral regions of the cytoplasm. To extend these obser-
vations, we determined the effect of agents that specifically
disrupt either the actin or microtubule networks. Target
cells were infected with GFP–Vpr-labeled HIV for 1 h and
then washed and observed at 37
 
 
 
C. Interestingly, after treat-
ment with either the microtubule inhibitor nocodazole or
the F-actin inhibitor latrunculin B movement of the GFP-
labeled particles was still observed. However, treatment with
both agents led to a cessation of movement. Washing out ei-
ther drug led to the rapid restoration of particle movement,
suggesting that HIV movement inside the cell depends on
both the actin and microtubule networks. Treatments that
retained or restored microtubule structure resulted in long
range particle movement; in contrast, actin structure sup-
ported short range, more erratic motility (unpublished data).
Figure 3. Movement of GFP–Vpr-tagged 
HIV particles in living cells. (A) HeLa/
CD4/CCR5 cells were infected with 
GFP–Vpr-labeled HIV (Bru3 env, MOI 
 1) (green) for 30 mn at 23 C, stained 
with MitoTracker (red), and mounted in 
a live cell chamber for observation at 
37 C. 14 0.5- m optical z-sections were 
acquired every 5 mn for 95 min and 
rendered in single three-dimensional 
volume views. Oval areas without 
mitochondrial signal are the nuclei of 
the cells. Individual HIV particles appear 
as several spots in some cases due to 
short rapid movement during acquisition 
of the z-series. The image is of the first 
time point, and white arrows denote the 
trajectories of four different particles 
over time. (B) Four time points depict the 
progression of the particle in the inset 
box. (C) Quantification of GFP–Vpr-
tagged HIV movement. HeLa/CD4 cells 
were infected for 20 min with GFP–Vpr-
labeled HIV, washed, and imaged every 
5 min. Particle position was measured at 
each time point, and relative nuclear 
migration is expressed as the fractional 
distance from the cell periphery to the 
nucleus (see diagram) so that low values 
represent peripheral localization and 
high values represent perinuclear 
localization. The five graphs track the 
movement of representative particles. 
Bars: (A) 10  m; (B) 4  m. See also videos 
1 and 2 available at http://www.jcb.org/
cgi/content/full/jcb.200203150/DC1. 
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To address the possibility that HIV might be tracking
along microtubules, we performed time-lapse experiments
with GFP–Vpr-tagged HIV-infected cells containing micro-
injected, fluorescently labeled tubulin (Fig. 4; see videos 1
and 2). For this study, virus with DiD-labeled membranes
was used to allow the identification of particles, which had
lost their membranes as would be expected after functional
entry into the cytoplasm. The labeled HIV was spinoculated
onto the target cells to increase the number of bound virions
(O’Doherty et al., 2000), and the cells were washed and ob-
served by fluorescent microscopy. Images were captured
every minute for a 14-min period. Several DiD-negative
particles are observed to migrate during the time course. Al-
though the microtubule network is dense because of the in-
jected tubulin, the tracking of DiD-negative particles along
microtubules is apparent. Two examples of movement along
microtubules are shown in Fig. 4 B. The particle designated
by the white arrow is likely the same throughout the panel;
however, the particle moved out of the plane of imaging for
a single frame so that it is possible that the movement of two
different DiD-negative particles is shown (see videos 1 and
2). In addition, the movement of DiD-negative particles not
 
associated with microtubules is also observed (Fig. 4 B, yel-
low arrow).
To assess a potential role for microtubules in the intracellu-
lar movement of GFP-labeled particles, we disrupted the func-
tion of cytoplasmic dynein. For this analysis, we microinjected
target cells with a monoclonal antibody to the 74-kD interme-
diate chain of the dyenin motor complex (IC74). It has been
reported that injection with this antibody can disrupt the mi-
crotubule-dependent minus end–directed movement of Ad
(Leopold et al., 2000). Target cells were injected with anti-
IC74 mixed with rhodamine-dextran as an injection marker
and infected with GFP–Vpr-tagged HIV containing labeled
membranes. Again we focused on DiD-negative particles,
which have lost their membrane coats and entered the cyto-
plasm. In uninjected cells, most of the DiD-negative particles
accumulated near the nucleus. In contrast, they accumulated
in the periphery of the injected cells (Fig. 5, A–C). Quantifica-
tion of the nuclear progression of the DiD-negative particles
demonstrates that in the injected cells the average DiD-nega-
tive particle made significantly less progress toward the nu-
cleus than in uninjected cells (Fig. 5 D, relative migration 
 
 
 
0.29 
 
 
 
 0.03 versus 0.58 
 
 
 
 0.04 in uninjected cells).
Figure 4. Microtubule-dependent and -independent movement 
of HIV particles in living cells. Hos/CD4 cells were microinjected 
with rhodamine-tubulin (Cytoskeleton) and incubated for 1 h at 
37 C to label microtubules (blue), spinfected with GFP–Vpr 
(green), and DiD (red)-labeled HIV Bru3 for 1 h at 1,200 g, 23 C. 
The cells were washed and placed in medium supplemented with 
50 mM Hepes and 0.1  M taxol to maintain microtubule structure. 
Images were collected every minute in the three color spectra at 
37 C. (A) Cell at the beginning time point. Nucleus is to the lower 
left, out of frame. (B) Two time segments depicting microtubule-
dependent (white arrow) and -independent (colored arrow) 
movement of DiD-negative particles. The particle on microtubules 
appears to be the same in both time segments, although assignment 
is ambiguous in one intermediate frame so that this could represent 
two independent particles moving on microtubules. See also 
videos 1 and 2 available at http://www.jcb.org/cgi/content/full/
jcb.200203150/DC1. Bars: (A) 10  m; (B) 5  m. 
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Identification of cytoplasmic reverse 
transcription complexes
 
To detect reverse transcription associated with the internal-
ized GFP-labeled particles, we injected a fluorescently la-
beled deoxynucleotide (Alexa-594–dUTP) into cells before
infection. Coverslips carrying microinjected CD4-express-
ing target cells were infected with GFP–Vpr-labeled HIV for
2 h, washed, and incubated for an additional 2 h. This ex-
tended period was found to result in optimal incorporation
of the fluorescent nucleotides into the cytoplasmic particles.
The cells were then fixed and immunostained for microtu-
bules (Fig. 6). The nucleus is brightly labeled with fluores-
cent dUTP as a consequence of incorporation of the micro-
injected nucleotide during cellular DNA replication. Two
GFP-labeled particles that have incorporated fluorescent
dUTP are readily apparent in the area of the MTOC (Fig. 6
B). The labeling is only seen under conditions where pro-
ductive infection can take place. For example, Alexa–dUTP
incorporation is only observed when the appropriate core-
ceptor is present as expected because proper receptor/core-
ceptor-mediated fusion and entry is required for the initia-
tion of reverse transcription (unpublished data). Because the
double labeled complexes have started the process of reverse
transcription, we will refer to them as reverse transcription
complexes (RTCs). Initial studies suggested that the RTCs
are associated with microtubules. Detergent extraction of
the cells before fixation resulted in significant loss of the
RTCs along with the microtubule network, but if taxol was
added to stabilize microtubules, RTCs were efficiently re-
tained, suggesting a stable, specific interaction with microtu-
bules (unpublished data).
To further explore the association of RTCs with microtu-
bules, we injected cells with fluorescent dUTP along with
the dynein inhibitor antibody (Fig. 7). RTCs in cells in-
jected with the anti-IC74 antibody exhibited reduced rela-
tive nuclear progression (0.23 
 
  
 
0.02) compared with
RTCs in cells injected with a control antibody (0.57 
 
 
 
0.03; Fig. 7 A). In addition, approximately threefold
more cytoplasmic RTCs could be identified in anti-IC74–
injected cells (Fig. 7 B), presumably because in control in-
jected cells the dynein motility resulted in nuclear accumu-
lation and entry, in which case the nuclear fluorescent
signal obscured the RTCs. These results reveal that HIV
RTCs use dynein motors to move along microtubules to
gain access to the nucleus.
We next determined whether HIV matrix and/or capsid
proteins could be detected in the RTC. It has been demon-
strated previously that HIV p17
 
MA
 
 is detectable in the prein-
tegration complex (PIC) but p24
 
CA
 
 is not (Miller et al.,
1997). Staining for p17
 
MA
 
 revealed that 95% (19 out of 20)
of the RTCs contained matrix. Surprisingly, we found that
many of the RTCs also contained significant amounts of
p24
 
CA
 
 (Fig. 8 C). Quantification of the fluorescent signal in
four independent experiments showed that 67 
 
 
 
 6% (
 
n
 
 
 
 
 
95) of the RTCs contained amounts of p24
 
CA
 
 similar to the
amount of p24
 
CA
 
 found in extracellular particles, suggesting
that the capsid in these particles was largely intact. On the
other hand, the remaining RTCs contained no detectable
p24
 
CA
 
 (Fig. 8 B). These results suggest that the capsid struc-
ture remains intact during the initiation of reverse transcrip-
tion in the cytoplasm. Interestingly, both the p24
 
CA
 
-positive
and -negative particles appear to associate with microtubules
Figure 5. Inhibition of dynein motor 
activity results in peripheral localization 
of HIV particles. (A) Cells were 
microinjected with antidynein IC74 
mAb (1.5 mg/ml) and rhodamine-dextran 
marker (cell outlined in blue; white 
outlines are uninjected cells), infected 
for 1 h with DiD (red)-labeled GFP–Vpr-
labeled HIV (green) at 37 C, and then 
fixed. (B and C) Magnification of boxed 
regions. Arrows show GFP-positive, 
DiD-negative particles in the perinuclear 
region of the uninjected cell (B) and 
peripheral region of the injected cell (C). 
(D) Quantification of DiD-negative 
particle progression toward the nucleus. 
Relative migration is calculated as 
described in Fig. 3. The graph represents 
the majority of particles in uninjected 
(none) and injected (IC74) cells from A. 
Bars, 10  m. 
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(Fig. 8, D and E), suggesting that the association occurs be-
fore loss of the capsid structure.
 
Electron microscopic analysis of RTCs
 
Our studies demonstrate that it is possible to identify com-
plexes that contain both GFP–Vpr and fluorescent nucle-
otides, and we propose that they represent steps in the HIV
life cycle known to take place after delivery of the viral core
into the cytoplasm. Because biophysical studies suggested
these complexes are rather large, we surmised that we should
be able to visualize RTCs by EM (Miller et al., 1997; Fassati
and Goff, 2001). To this end, we adapted a method of cor-
relative EM which was developed to visualize the cytoskele-
ton (Svitkina and Borisy, 1998). The technique allows the
imaging of individual cells at both the light and electron mi-
croscopic levels. Key to this method is the growth of cells on
coverslips that are gold-embossed with the image of an EM
locator grid. The grid can be visualized by both light and
electron microscopes, allowing relocation of individual cells
using both methods. Because this method utilizes platinum
replicas for the EM analysis, only very flat regions of the cells
can be efficiently visualized. Therefore, we used human
primary fibroblasts for this study. Because native HIV can-
not infect cells without CD4 expression, we used envelope-
defective HIV that we pseudotyped with the vesicular stoma-
titis virus envelope glycoprotein (VSV-G), which allows
infection of primary human fibroblasts. Although VSV-G
directs cellular entry by a distinct mechanism (CD4 and core-
ceptor fusion at the plasma membrane for gp120 as opposed
to fusion out of acidified endosomes for VSV-G), the con-
tents of viral particles delivered to the cytoplasm are derived
from the same HIV structural proteins, and it is generally
believed that the postfusion events of the delivered genome
are similar to the normal HIV life cycle. Cells were injected
with fluorescent dUTP, infected with VSV-G–pseudotyped,
GFP–Vpr-labeled HIV for 4 h, extracted with detergent in
the presence of taxol, and treated with gelsolin to deplete the
actin cytoskeleton before fixation. Cells were imaged on a
fluorescent microscope and then further processed for EM
by platinum rotary shadowing. This technique permits the
unambiguous identification of the unique microtubule ar-
chitecture of individual cells, allowing precise localization of
associated complexes (Fig. 9). An example of the correlation
of the fluorescent (Fig. 9 A) and EM image (Fig. 9 B) is
shown in Fig. 9 C. A high magnification EM image of the
Figure 6. Deoxynucleotide labeling of 
cytoplasmic reverse transcription 
complexes. (A) Target cells expressing 
CD4 were injected with Alexa–dUTP 
(red) (1mM in PBS; Molecular Probes), 
infected with GFP–Vpr-labeled HIV 
(green) (MOI  10) for 2 h at 37 C, 
washed and incubated 2 h more before 
fixation. Microtubules (blue) were 
stained with antitubulin antibody. Large 
arrow denotes the MTOC, and small 
arrows show viral particles, which have 
incorporated the Alexa–dUTP. (B and C) 
Magnification of the MTOC region. Note 
the overlap of green (GFP) and red 
(dUTP) signals in the two particles, 
resulting in yellow color. Bars: (A) 10  m; 
(B and C) 2  m.
Figure 7. Inhibition of dynein motor activity results in reduced 
nuclear migration of HIV RTCs. (A and B) Hos/CD4/CCR5 cells 
were coinjected with Alexa–dUTP (0.5 mM) mixed with an isotype-
matched IgG mAb (Control) or antidynein mAb (IC74), and infected 
with GFP–Vpr-labeled HIVYu (MOI  10) for 2 h at 37 C; medium 
was refreshed, and cells were incubated an additional 2 h. Cytoplasmic 
RTCs were identified, and their nuclear progression was quantified 
as in the legend to Fig. 3. Columns are average values   SEM of four 
independent experiments. n, the total number of RTCs quantified. 
(B) The average number of RTCs/cell from the experiments described 
in A. Columns are the average number   SEM. n, the number of 
cells evaluated. 
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structure correlating with the RTC is shown in Fig. 9 D.
This RTC appears to be a closed cylinder 
 
 
 
100 nm by 400
nm, with an interesting cauliflower-like protrusion at one
end. Also apparent is a stalk-like structure linking the RTC
to the microtubule, similar to that seen tethering HSV-1
capsids to microtubules (Sodeik et al., 1997).
Due to the complexity of the cytoskeleton in the interior
of cells, it is necessary to image structures in peripheral re-
 
gions of the cytoplasm. This presents a significant problem
for our analysis because the RTCs tend to move inward dur-
ing infection. Nevertheless, we have identified several periph-
eral RTCs associated with microtubules following this proce-
dure and have succeeded in acquiring several EM images of
intracellular RTC structures (Fig. 9, D and E
 
 
 
–H
 
 
 
). Al-
though the length of the RTCs varied from 400 to 700 nm,
they all had a diameter of 100 
 
 
 
 26 nm. The RTCs identi-
fied show similar size and structure with some variation, pos-
sibly due to the nature of the imaging technique (the quality
of the image is dependent on several variables, including the
orientation of the particle to the plane of focus) or possibly
reflecting different stages of RTC maturation.
 
Discussion
 
Fluorescent imaging of intracellular HIV
 
Currently little is known about the intracellular path that
the HIV genome takes after it enters the cytoplasm follow-
ing envelope-mediated fusion with the plasma membrane.
To analyze the behavior of the viral genome complex, we
have developed several methods that allow the in situ iden-
tification of viral components. Key among these methods is
exploitation of the property of HIV Vpr to package into
virions and remain associated with the viral genome in the
cytoplasm of infected cells. By tethering GFP to Vpr, we
can detect virions and intracellular particles by fluorescent
microscopy. We have confirmed by five different criteria
that the GFP signal marks genuine HIV-derived complexes:
sedimentation of GFP–Vpr with viral proteins, colocaliza-
tion with p24
 
CA
 
, p17
 
MA
 
, and virion membranes, and the as-
sociation of reverse transcriptase activity in infected cells.
The composition of the HIV-derived complexes is consis-
tent with the composition of bona fide viral particles.
p17
 
MA
 
 and p24
 
CA
 
 are virtually always found associated with
extracellular GFP–Vpr as is expected for intact virions. The
intracellular complexes with reverse transcriptase activity all
contain p17
 
MA
 
, which is known to remain associated with
the viral genome after the completion of reverse transcrip-
tion (Miller et al., 1997).
An important consideration in efforts to observe cytoplas-
mic complexes containing the HIV genome is the ability to
distinguish productive from nonproductive binding events.
HIV is considered to be relatively inefficient at infecting cells,
with infectivity to particle ratios reported to be as low as 1 in
60,000 (Kimpton and Emerman, 1992; Piatak et al., 1993).
However, more appropriate measures of infectivity, that is the
fraction of particles which bind to the cell that cause an infec-
tious event, suggest a ratio up to 1 in 10 for retroviruses (An-
dreadis et al., 2000). Even at this level of infectivity, it was
necessary for us to distinguish between productive and non-
productive entry. For this reason, we focused on two types of
GFP-tagged particles: those that had lost a membrane dye,
suggesting they had fused with the cellular membrane, and
those which had incorporated deoxynucleotides. In both
cases, these particles represent a subset of HIV that had en-
tered the cytoplasm of the target cells to form viral complexes
which are competent to complete the infectious cycle.
Our time-lapse studies of internalized viral particles sug-
gested both microtubule-dependent and microtubule-inde-
Figure 8. Some HIV reverse transcription complexes contain 
p24
CA protein. Hos cells that express CD4 and CCR5 were injected 
with Alexa–dUTP (red) and infected with GFP–Vpr-labeled YU 
strain of HIV (green) (MOI  10) for 4 h, fixed, and stained with 
p24
CA antibody. (A) Perinuclear region of a cell with some nuclear 
incorporation of Alexa–dUTP. (B) Merged (left) and individual color 
images of a p24
CA-negative RTC. Note the presence (top right) of a 
dUTP-negative, p24
CA-positive particle. (C) Merged and individual 
images of p24
CA-positive RTCs. (D) p24
CA-positive and -negative 
RTCs associate with microtubules. Microtubules (blue) were stained 
in addition to p24
CA, and images were collected in four color spectra. 
(E) Shows the same two RTCs without microtubules, and (F) shows 
the p24
CA (blue) staining profile. Bars: (A) 5  m; (B–F) 2  m. 
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pendent cytoplasmic movement. Since disruption of both
actin and microtubule was necessary to completely halt mo-
tility the microtubule-independent movement may use ac-
tin. Previous studies have found that disrupting the actin
network inhibits infection with HIV, and it was proposed
that actin-based motility is important either for cytoplasmic
entry (Iyengar et al., 1998) or for establishment of an infec-
tious viral complex (Bukrinskaya et al., 1998). However,
further study is required to determine if the microtubule-
independent movement is directed through interaction with
the actin cytoskeleton or by some other mechanism.
Role for cytoplasmic dynein in intracellular 
motility of HIV
Our studies suggest that HIV RTCs use the microtubule
network for long range movement within cells. Most of the
GFP–Vpr-labeled particles were found to be associated with
Figure 9. Electron microscopic analysis 
of cytoplasmic RTC structure. Fibroblasts 
were injected with Alexa–dUTP (red) 
and infected with GFP–Vpr-labeled 
VSV-G pseudotyped HIV (MOI  50–100, 
green) for 4 h. Cell membranes were 
extracted with 1% Triton X-100 containing 
taxol, actin was depleted by gelsolin 
treatment, and the cells were washed, 
fixed, and immunostained with an 
antitubulin mAb (blue). Cells were imaged 
with a fluorescence microscope and 
then processed for Pt rotary shadowing 
and relocated on the electron microscope. 
Microtubules with associated RTC (arrow) 
in immunofluorescent (A) and electron 
microscopic (B) images were aligned 
and overlayed (C). (D) High magnification 
image of the RTC in A–C. Immuno-
fluorescent (E–H) and EM images (E’–H’) 
of four RTCs, three of which (F–H) appear 
to be tethered to microtubules. Bars: 
(A and B) 10  m; (C and E–H) 1  m; 
(D and E’–H’) 0.1  m.450 The Journal of Cell Biology | Volume 159, Number 3, 2002
microtubules. Over 80% (16 of 19) of the GFP–Vpr-labeled
complexes that were also labeled with fluorescent nucle-
otides were associated with microtubules in Triton X-100–
extracted cells (unpublished data). We documented move-
ment of GFP–Vpr-labeled HIV along fluorescently labeled
microtubules using time-lapse microscopy. Further, prelimi-
nary analysis suggests that the DiD-negative, GFP-labeled
particles can move at burst velocities on the order of 1  /s, a
rate consistent with that known for microtubule based mo-
tors (Presley et al., 1998). We visually demonstrated that
GFP–Vpr-labeled complexes extracted from infected cells
with saponin could bind to fluorescently labeled microtu-
bules generated in vitro (unpublished data). Finally, attach-
ments between the RTC and microtubules were detected
ultrastructurally using correlative EM. Association with mi-
crotubules was apparently not cell type specific because the
interaction was detected in Hos, HeLa, and primary fibro-
blast cells. The likely function of the microtubule-based mo-
tility is to transport the HIV genome from the cell periphery
to the nucleus.
Other viruses use dynein-mediated transport along mi-
crotubules to gain access to the nucleus. To determine the
role of dynein in the movement of HIV particles along mi-
crotubules, we inhibited its motor function by microinjec-
tion of an inhibitory monoclonal antibody. After infection,
GFP–Vpr-labeled particles defined as entering the cyto-
plasm either by the loss of membrane label or by the incor-
poration of fluorescent nucleotides remained in the periph-
ery of injected cells relative to adjacent uninjected cells. In
cells with inhibited dynein function, the particles were clus-
tered at points most distant from the nucleus of the infected
cell. Preliminary studies suggest that the mislocalization was
due to a reversal of the dominant, microtubule minus end–
directed movement seen in uninjected cells (unpublished
data). Studies of Ad-2 mobility in living cells revealed a sim-
ilar pattern when dynein function was inhibited by overex-
pression of p50 dynamitin (Suomalainen et al., 1999). The
Ad-2 mislocalization is thought to be a consequence of
plus end microtubule activity associated with the motor
complex used by this virus. Additional evidence for a plus
end–directed activity lies in the observation that Ad-2 oscil-
lates on the microtubules between short range plus end and
minus end movements, very similar to the type of motility
we have observed with HIV. This oscillation is not seen with
Ad-5, and disruption of dynein in that case results in cessa-
tion of movement, not with plus end–directed motion (Leo-
pold et al., 2000). Our studies suggest that HIV uses a mo-
tor complex with similarities to the one used by Ad-2.
It has been reported previously that disruption of the mi-
crotubule network by nocodazole treatment inhibits HIV
infection by approximately twofold (Bukrinskaya et al.,
1998). We have obtained similar results in this type of
study (unpublished data). Nocodazole treatment during
HSV and Ad-2 infection has also been shown to decrease
the efficiency but not prevent infection (Sodeik et al., 1997;
Suomalainen et al., 1999). Several possibilities have been
proposed to explain this incomplete inhibition, including
entry proximal to the nucleus, transport along nocodazole-
resistant microtubules, or movement by Brownian motion
(Mabit et al., 2002).
Initiation of reverse transcription in cytoplasmic HIV 
containing p24
CA
There has been much speculation about the cytoplasmic fate
of the conical capsid that contains the HIV genome inside
virions. In some models, the capsid dissolves immediately af-
ter membrane fusion. Others propose that the capsid re-
mains intact until the genome reaches a nuclear pore. The
conical core is a relatively unstable complex that is sensitive
to all but the most mild detergent treatments. Recently,
methods have been developed which allow the isolation of
large amounts of HIV cores from virions (Kotov et al., 1999;
Accola et al., 2000; Wilk et al., 2001), although intact cores
have not been isolated from infected cells. Our in situ analy-
ses identified two distinct species of GFP–Vpr-labeled com-
plexes associated with reverse transcriptase activity, one lack-
ing p24
CA and the other containing significant amounts of
p24
CA, suggesting that the capsid is intact in the latter com-
plexes. Structural studies of the HIV capsid have suggested
the presence of pores large enough to allow entry of nucle-
otides into the capsid (Li et al., 2000). Further, the ability to
facilitate reverse transcription within intact virions by expo-
sure to high concentrations of deoxynucleotides along with
polyanions also suggests that reverse transcription within in-
tact capsids is possible (Zhang et al., 1996). Previous bio-
chemical studies have not identified significant amounts of
p24
CA associated with the RTC. However the conditions
typically used to generate lysates for RTC and PIC purifica-
tion may confound this analysis because the HIV capsid eas-
ily disassembles in the presence of detergents or possibly in
the low salt conditions of hypotonic lysis (Ganser et al.,
1999; Kotov et al., 1999; Accola et al., 2000; Wilk et al.,
2001). This study provides the first evidence of reverse tran-
scription within an intact HIV capsid in the cytoplasm of an
infected cell, suggesting that the capsid remains intact for at
least a portion of the process from the initiation of reverse
transcription to maturation of the PIC. Furthermore, the
p24
CA containing RTCs are associated with microtubules
(Fig. 9), suggesting that this association with the microtu-
bule network can occur before loss of the capsid. Alterna-
tively, the p24
CA-associated RTC may reflect dead end
events due to a failure of capsid dissolution after fusion.
Ultrastructure of cytoplasmic RTCs
To gain insight into the morphology of the cytoplasmic
RTC, we adapted a correlative electron microscopic tech-
nique used previously to study the cytoskeleton. This
method uses the alignment of fluorescent and platinum rep-
licas of detergent extracted cells. Unfortunately, this method
only allows visualization a short distance into the cell, and
therefore, only RTC in the periphery could be imaged. Us-
ing EM, we find structures overlapping with the fluores-
cently visualized RTC. They are typically cylindrical in
shape with varying length and a very similar diameter. Previ-
ous biophysical characterization of cytoplasmic HIV RTC
derived from acutely infected cells suggests that the compo-
sition of the RTC is dynamic over time (Fassati and Goff,
2001); while the density of these complexes remains con-
stant, the sedimentation velocity of complexes containing
HIV proviral DNA increased at later time points. This ob- HIV visualization | McDonald et al. 451
servation suggests that protein–DNA complexes with a
range of sizes and/or shapes are found in the cytoplasm at
different times during reverse transcription. The large size of
the RTCs identified in the periphery by correlative EM is
most consistent with the early, larger complexes detected in
the previous studies. Alternatively, the detergent treatment
of the infected cells required for our method may lead to an
increase in the size of complexes detected. In either case, the
structures we propose to be RTCs are consistent with previ-
ous biophysical descriptions. Further study, including im-
munogold staining for viral proteins and analysis of com-
plexes generated after entry mediated by the HIV envelope
will clarify if the observed structures are bona fide cytoplas-
mic RTCs. In most cases the RTC cylinder is overlapping a
microtubule or connected to a microtubule by a stalk-like
projection. The observed connections between the identified
complexes and microtubules is consistent with our model
that intracellular HIV complexes are using the microtubule
network to move within the cytoplasm.
Our observations of the composition and trafficking of in-
tracellular HIV complexes suggests the following scenario.
After entering the cytoplasm, the HIV genome uses some as-
pect of the actin cytoskeleton to move within the peripheral
regions of the cell. This is consistent with evidence that actin
can be used to gain access to the microtubule network
(Taunton, 2001). It is also supported by previous reports
that an intact actin cytoskeleton is necessary for efficient in-
fectivity (Bukrinskaya et al., 1998). The infectious viral par-
ticle must next make its way to the microtubule network,
where it can initiate reverse transcription even before losing
the majority of its capsid protein. At some point after inter-
action with the microtubule network, the conical capsid dis-
sociates, yet the RTC maintains its interaction with micro-
tubules. This interaction is likely mediated by tethering with
a cellular motor complex which has both minus end– and
plus end–directed motor activities, as is proposed for Ad-2.
Minus end–directed movement of the RTC along the mi-
crotubule network ultimately leads to the microtubule orga-
nizing center, very near the nuclear membrane, where the
mature RTC can then enter through nuclear pore complexes
in order to integrate into the host DNA.
Materials and methods
Cells and antibodies
MAGI cells are a HeLa cell line stably transfected with human CD4 and
HIV–long terminal repeat promoter– -galactosidase genes maintained in
complete DME medium as described (Kimpton and Emerman, 1992).
HOST4R5 are a human osteosarcoma cell line expressing hCD4 and
hCCR5 (provided by Dr. Ned Landau, The Salk Institute) also maintained in
complete DME medium. GHOST cells additionally express an HIV–long
terminal repeat promoter–GFP construct. Human primary fibroblasts
(American Type Culture Collection no. CRL-2522) are maintained in com-
plete RPMI medium. mAb AG3.0 recognizes HIV gag p24
CA and the
p55
GAG precursor (National Institutes of Health AIDS Research and Refer-
ence Reagent Program). mAb anti-HIV p17 (Capricorn Products) recog-
nizes HIV gag p17
MA. Antidynein intermediate chain mAb (anti-IC74)
(Chemicon International) is prepared for microinjection by sequential con-
centration and dilution in PBS in a microcon concentrator (Millipore, Inc.)
to remove azide. The ability of the antibody to retard nuclear accumulation
of HIV particles was titered and found to require  1 mg/ml for optimal ef-
fect. Isotype-matched control antibody (IgG2b; R & D Systems) was used at
the same concentration. Alexa-594–dUTP (Molecular Probes) is diluted in
PBS or the appropriate antibody to 0.5 mM. Microtubules are immu-
nostained with anti– -tubulin mAb (Sigma-Aldrich). Actin fibers are stained
with Texas red–labeled phalloidin (Molecular Probes). All secondary anti-
bodies are fluorescent-labeled donkey anti–mouse antibodies (Jackson Im-
munoResearch Laboratories). Microinjection was performed using an Ep-
pendorf Transjector model 5246. Cells growing on a coverslip in a dish
containing media with 50 mM Hepes, pH 7.5, are placed on a warming
stage on the microscope, microinjected into the cytoplasm, and then re-
turned to a CO2 incubator to recover for a short time before further manip-
ulation. Rhodamine-labeled tubulin (5 mg/ml; Cytoskeleton) is injected 2 h
before infection to allow incorporation into the microtubule network.
Virus production
GFP–Vpr-labeled HIV is produced by CaPO4 transfection of 293T cells
with the proviral constructs pLAI or pLAI-Yu (Yu2 env in the pLAI back-
bone) (Vodicka et al., 1998) and the plasmid peGFPC3 (CLONTECH Labo-
ratories, Inc.) containing the entire Vpr-coding region fused to the COOH
terminus of eGFP (GFP–Vpr). Cells are washed at 16–20 h posttransfection,
medium is replaced at 36 h, and supernatants containing labeled virus is
collected at 2–4-h intervals for two or three harvests. For pseudotyped
HIV, an env-deleted pLAI provirus, VSV-G expression plasmid, and the
GFP–Vpr plasmid are cotransfected. Virus is collected as above and con-
centrated by ultracentrifugation for 2 h at 23,000 rpm through a 20% su-
crose pad and resuspended in PBS at 50–100-fold concentration (Bartz
and Vodicka, 1997). Purification of virus by gradient centrifugation was
performed using an Optiprep (Nycomed) density gradient as described
(Dettenhofer and Yu, 1999). DiD (DiIC18; Molecular Probes) labeling was
achieved by addition of DiD (10  M) after the initial wash, rinsing away
unincorporated dye the next morning, and collecting supernatants as
above. All virus preparations were assayed for infectivity using MAGI indi-
cator cells, and the GFP–Vpr incorporation was assessed by p24
CA staining
of virions bound to glass using mAb AG3.0.
Immunofluorescence
Cells are grown on glass coverslips, rinsed with PBS, and fixed with 3.7%
formaldehyde (Polysciences) in 0.1 M Pipes, pH 6.8. Antibodies are added
at predetermined dilutions in SB (PBS, 10% normal donkey serum [Jackson
ImmunoResearch Laboratories], 0.1% Triton X-100) for 20 min at RT. Cov-
erslips are rinsed extensively and stained with labeled (AMCA-, Cy3- or
Cy5-) donkey anti–mouse antibodies (Jackson ImmunoResearch Laborato-
ries) in SB. Coverslips are then mounted onto glass slides with Gel Mount
(Biomedia) containing an antifade reagent. Dried slides are imaged on an
Olympus IX70 epifluorescent microscope fitted with an automated stage
(Applied Precision Inc.), and images are captured in z-series on a CCD dig-
ital camera. Out of focus light is digitally removed using the Softworks de-
convolution software (Applied Precision Inc.). Live cell video microscopy
is performed using a heated open or closed cell chamber along with an ob-
jective heater (Bioptechs Inc.), and cells are maintained on coverslips in
medium supplemented with 50 mM Hepes, pH 7.5.
Quantification of nuclear migration
Particle location is determined by measuring the distances to the nearest
edge of both the nucleus and the cell periphery using the Deltavision Soft-
works program and is expressed as the fraction of the distance to the edge
divided by the total distance so that particles at the periphery have values
approaching 0 and nuclear particles approaching 1. For Figs. 3 and 5, the
image z-series were first projected as a single image using the three-dimen-
sional reconstruction feature of the software. As a result, it is not possible
to measure particles directly over the nucleus so these particles were ex-
cluded from the analysis. For Fig. 7, RTCs that are over the nucleus are
generally obscured by the strong nuclear Alexa–dUTP signal.
Correlative EM
Cytoskeletal samples are prepared as described (Svitkina and Borisy, 1998)
with modifications. Briefly, primary fibroblast cells are grown on glass cov-
erslips patterned by evaporation of gold onto an EM locator grid. Cells are
injected with Alexa-594–dUTP (Molecular Probes), infected with GFP–
Vpr-labeled, VSV-G pseudotyped HIV at high titer (MOI  50–100), and
incubated for 4 h at 37 C. Coverslips are then extracted with 1% Triton
X-100, 4% PEG mol wt 40 kD (SERVA Biochemicals), and 10 mM taxol
(Sigma-Aldrich) in PEM buffer (80 mM Pipes, pH 6.8, 1 mM EGTA, 1 mM
MgCl2). Actin is depleted by incubation in G’ buffer containing taxol and
gelsolin (3 mg/ml; provided by S. Choe, The Salk Institute) at RT for 1 h.
Cells are rinsed and fixed with 2% glutaraldehyde and immunostained
with anti– -tubulin and Cy5 donkey anti–mouse secondary. Injected cells
are imaged on an epifluorescent microscope, and the locations of candi-
date cells are noted with respect to the grid pattern. Samples are prepared452 The Journal of Cell Biology | Volume 159, Number 3, 2002
for EM analysis by desiccation in ethanol and dried in a critical point dryer.
They are then coated with platinum in a rotary vacuum evaporator fol-
lowed by carbon coating to maintain structure. Candidate cells are
mounted on formvar-coated EM grids and examined on a JEOL 1220 elec-
tron microscope. The unique microtubule structure is used to digitally
align the immunofluorescent and EM images using Adobe Photoshop
®
software.
Online supplemental material
Figs. 3 and 4 time-lapse images are compiled into Quicktime videos avail-
able at http://www.jcb.org/cgi/content/full/jcb.200203150/DC1. Video 1
shows the movement of HIV particles in living cells depicted in Fig. 3.
HeLa/CD4/CCR5 cells were infected with GFP–Vpr-labeled HIV (green),
stained with MitoTracker (red), and mounted in a live cell chamber for ob-
servation at 37 C. 14 0.5- m optical z-sections were acquired every 5 mn
for 95 min (20 frames) and rendered in single three-dimensional volume
views. The video is displayed at 1 s/frame. Individual HIV particles appear
as several spots in some cases due to short rapid movement during acquisi-
tion of the z-series. Video 2 shows microtubule-dependent and -indepen-
dent movement of HIV particles in living cells as depicted in Fig. 4. Hos/
CD4 cells were microinjected with rhodamine-tubulin and incubated for
1 h at 37 C to label microtubules (blue), spinfected with GFP–Vpr (green),
and DiD (red)-labeled HIV for 1 h at 1,200 g, 23 C. The cells were washed
and placed in medium supplemented with 50 mM Hepes and 0.1  M
taxol. Images were collected every minute for 14 min (15 frames) in the
three color spectra at 37 C. Video 1 shows the full frame images displayed
at 1 s/frame, showing the movement of many particles near microtubules
and in areas devoid of microtubules. Video 2 is a close-up of a region,
showing microtubule-dependent (white arrow) and -independent (yellow
arrow) movement.
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